Yan Zeng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yan Zeng has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Jun Zheng
Department of Stomatology, Central People's Hospital of Zhanjiang, Zhanjiang, 524037, Guangdong, China
3 shared publications- Tiejun Zhang
Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China
3 shared publications - Zhenqiu Liu
Human Phenome Institute, Research and Innovation Center, Shanghai Pudong Hospital, Fudan University, Shanghai, China
3 shared publications Han Liu
Precision Clinical Laboratory, Central People's Hospital of Zhanjiang, Zhanjiang, Guangdong, 524037, Guangdong, China
2 shared publications- Bishi Fu
State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China
1 shared publication Charles Wood
Nebraska Center of Virology and the School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, USA
1 shared publication
Latest Publications
- Open Access
- 7 August 2025
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 881
miR-107 modulates EMT progression of OSCC by targeting SNCG and inhibiting the ERK/NF-κB signaling pathways
Oral squamous cell carcinoma (OSCC) is marked by aggressive metastasis and poor prognosis, with epithelial-mesenchymal transition (EMT) serving as a pivotal process in tumor metastasis. Consequently, identifying critical targets and elucidating the underlying mechanisms that drive OSCC metastasis are vital for enhancing patient prognosis. This study sought to clarify the significance and underlying molecular mechanisms of the miR-107/synuclein gamma (SNCG) axis in the regulation of OSCC migration, invasion, and EMT progression. Peripheral blood from 26 OSCC patients and 24 controls assessed miR-107 expression, with GEO analysis for clinical significance. The effects of miR-107 and SNCG on OSCC migration, invasion and EMT in vivo and in vitro were assessed via wound healing, Transwell assays, qRT-PCR, WB and xenograft model. miR-107 was downregulated, while SNCG was upregulated in OSCC tissues. miR-107 served as a direct regulator of SNCG, leading to its downregulation. Gain- and loss-of-function studies demonstrated that SNCG promoted OSCC cell migration, invasion and EMT progression, while miR-107 inhibited EMT and exerted the opposite effect. These findings were confirmed in a nude mouse model, where miR-107 counteracted SNCG-induced tumor growth and EMT progression. Mechanistically, SNCG increased ERK1/2 and NF-κB p65 phosphorylation without altering total protein levels, while miR-107 mimic partially reversed these effects, suggesting that the miR-107/SNCG axis regulates migration, invasion and EMT progression through the ERK1/2 and NF-κB pathways. Overall, our findings elucidated that miR-107 attenuated migration and EMT in OSCC by targeting SNCG and inhibiting the ERK1/2/NF-κB pathway, providing novel potential therapeutic targets for OSCC.
- 7 August 2025
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 881
Open AccessmiR-107 modulates EMT progression of OSCC by targeting SNCG and inhibiting the ERK/NF-κB signaling pathways
Oral squamous cell carcinoma (OSCC) is marked by aggressive metastasis and poor prognosis, with epithelial-mesenchymal transition (EMT) serving as a pivotal process in tumor metastasis. Consequently, identifying critical targets and elucidating the underlying mechanisms that drive OSCC metastasis are vital for enhancing patient prognosis. This study sought to clarify the significance and underlying molecular mechanisms of the miR-107/synuclein gamma (SNCG) axis in the regulation of OSCC migration, invasion, and EMT progression. Peripheral blood from 26 OSCC patients and 24 controls assessed miR-107 expression, with GEO analysis for clinical significance. The effects of miR-107 and SNCG on OSCC migration, invasion and EMT in vivo and in vitro were assessed via wound healing, Transwell assays, qRT-PCR, WB and xenograft model. miR-107 was downregulated, while SNCG was upregulated in OSCC tissues. miR-107 served as a direct regulator of SNCG, leading to its downregulation. Gain- and loss-of-function studies demonstrated that SNCG promoted OSCC cell migration, invasion and EMT progression, while miR-107 inhibited EMT and exerted the opposite effect. These findings were confirmed in a nude mouse model, where miR-107 counteracted SNCG-induced tumor growth and EMT progression. Mechanistically, SNCG increased ERK1/2 and NF-κB p65 phosphorylation without altering total protein levels, while miR-107 mimic partially reversed these effects, suggesting that the miR-107/SNCG axis regulates migration, invasion and EMT progression through the ERK1/2 and NF-κB pathways. Overall, our findings elucidated that miR-107 attenuated migration and EMT in OSCC by targeting SNCG and inhibiting the ERK1/2/NF-κB pathway, providing novel potential therapeutic targets for OSCC.
- Open Access
- 1 March 2025
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 17, 589-602
Diagnostic Efficacy and Clinical Significance of Lymphocyte Subsets, Granzyme B and Perforin in the Peripheral Blood of Patients with Invasive Breast Cancer Following Neoadjuvant Chemotherapy
Purpose: Breast cancer, a predominant contributor to cancer-related mortality worldwide, is increasingly managed through the application of neoadjuvant chemotherapy (NAC). Analyzing the dynamic changes in peripheral blood lymphocyte subsets, granzyme B and perforin are crucial for investigating their roles in tumorigenesis, development and treatment; this study aimed to use these analyses to diagnose malignant breast tumor, assess the anti-tumor immunity and predict chemotherapy efficacy in breast cancer patients. Patients and Methods: To address this objective, a total of 582 peripheral blood samples were collected from healthy controls (n=47), benign breast disease patients (n=401) and breast cancer patients (n=134). Lymphocyte subsets, along with granzyme B and perforin expression, were assessed using flow cytometry. Changes before and after NAC were also monitored. Results: Breast cancer patients exhibited reduced proportions and absolute counts of CD3+ and CD8+ T cells, increased NK cell percentage and CD4+/CD8+ ratio, and higher levels of granzyme B and perforin in CD3+, CD8+ T cells and NK cells. Post-NAC, the percentages of CD3+, CD4+, CD8+ T cells and NK cells increased, along with a higher CD4+/CD8+ ratio, while B cell percentages decreased compared to pre-NAC. Furthermore, the effective group showed higher percentages of CD3+, CD8+ T cells and lower percentages of B cells than the ineffective group post-NAC. Incidentally, Granzyme B and perforin expression in CD3+ and CD8+ T cells was elevated following postoperative chemotherapy. Conclusion: These findings indicated that peripheral blood lymphocyte subsets, along with granzyme B and perforin levels, could serve as potential biomarkers for differentiating benign from malignant breast tumors, assessing anti-tumor immunity and predicting chemotherapy efficacy.
- 1 March 2025
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 17, 589-602
Open AccessDiagnostic Efficacy and Clinical Significance of Lymphocyte Subsets, Granzyme B and Perforin in the Peripheral Blood of Patients with Invasive Breast Cancer Following Neoadjuvant Chemotherapy
Purpose: Breast cancer, a predominant contributor to cancer-related mortality worldwide, is increasingly managed through the application of neoadjuvant chemotherapy (NAC). Analyzing the dynamic changes in peripheral blood lymphocyte subsets, granzyme B and perforin are crucial for investigating their roles in tumorigenesis, development and treatment; this study aimed to use these analyses to diagnose malignant breast tumor, assess the anti-tumor immunity and predict chemotherapy efficacy in breast cancer patients. Patients and Methods: To address this objective, a total of 582 peripheral blood samples were collected from healthy controls (n=47), benign breast disease patients (n=401) and breast cancer patients (n=134). Lymphocyte subsets, along with granzyme B and perforin expression, were assessed using flow cytometry. Changes before and after NAC were also monitored. Results: Breast cancer patients exhibited reduced proportions and absolute counts of CD3+ and CD8+ T cells, increased NK cell percentage and CD4+/CD8+ ratio, and higher levels of granzyme B and perforin in CD3+, CD8+ T cells and NK cells. Post-NAC, the percentages of CD3+, CD4+, CD8+ T cells and NK cells increased, along with a higher CD4+/CD8+ ratio, while B cell percentages decreased compared to pre-NAC. Furthermore, the effective group showed higher percentages of CD3+, CD8+ T cells and lower percentages of B cells than the ineffective group post-NAC. Incidentally, Granzyme B and perforin expression in CD3+ and CD8+ T cells was elevated following postoperative chemotherapy. Conclusion: These findings indicated that peripheral blood lymphocyte subsets, along with granzyme B and perforin levels, could serve as potential biomarkers for differentiating benign from malignant breast tumors, assessing anti-tumor immunity and predicting chemotherapy efficacy.
- 15 October 2018
- Published by Wiley in Journal of Medical Virology
- Vol. 91 (3) , 457-462
Social behavioral correlates of Kaposi sarcoma–associated herpesvirus infection among Han and Uygur populations in Xinjiang, China
Background: Kaposi sarcoma–associated herpesvirus (KSHV) is endemic in Xinjiang, China and its prevalence varies considerably across ethnic groups. The current study explored the prevalence and correlates of KSHV infection among Han and Uygur populations in Xinjiang.Methods: A cross‐sectional study, including 282 Han ethnicity and 312 Uygur, was conducted in Xinjiang, China. All participants underwent face to face questionnaire interview. Plasma samples were collected and screened for KSHV infection using immunofluorescence assay. Univariate and multivariate analyses were conducted to examine the correlates of KSHV seropositivity.Results: The KSHV seroprevalence was 41.6% (95% confidence interval [CI], 37.6‐45.6) overall and was higher in the Uygur group (59.9%; 95% CI, 54.3‐65.4) than the Han group (21.3%; 95% CI, 16.6‐26.5). A significant difference in the geometric mean titer (GMT) of the KSHV antibodies was detected between the Uygur and Han groups (158.2; interquartile range [IQR], 80‐320 vs 89.1; IQR, 40‐160; P < 0.001). After adjusting for potential confounders, Uygur ethnicity (odds ratios [OR], 5.96; 95% CI, 4.05‐8.90), age greater than or equal to 50 years (OR, 1.84; 95% CI, 1.24‐2.77), and preference for meat diet (OR, 2.15; 95% CI, 1.05‐4.46) were significantly associated with increased odds of KSHV seropositivity.Conclusion: The study demonstrated high prevalence and correlates of KSHV infection in both Han and Uygur populations in Xinjiang, China. There is an urgent need for programmatic adaptation to address primary prevention interventions of KSHV infection in this endemic region.
- 15 October 2018
- Published by Wiley in Journal of Medical Virology
- Vol. 91 (3) , 457-462
Social behavioral correlates of Kaposi sarcoma–associated herpesvirus infection among Han and Uygur populations in Xinjiang, China
Background: Kaposi sarcoma–associated herpesvirus (KSHV) is endemic in Xinjiang, China and its prevalence varies considerably across ethnic groups. The current study explored the prevalence and correlates of KSHV infection among Han and Uygur populations in Xinjiang.Methods: A cross‐sectional study, including 282 Han ethnicity and 312 Uygur, was conducted in Xinjiang, China. All participants underwent face to face questionnaire interview. Plasma samples were collected and screened for KSHV infection using immunofluorescence assay. Univariate and multivariate analyses were conducted to examine the correlates of KSHV seropositivity.Results: The KSHV seroprevalence was 41.6% (95% confidence interval [CI], 37.6‐45.6) overall and was higher in the Uygur group (59.9%; 95% CI, 54.3‐65.4) than the Han group (21.3%; 95% CI, 16.6‐26.5). A significant difference in the geometric mean titer (GMT) of the KSHV antibodies was detected between the Uygur and Han groups (158.2; interquartile range [IQR], 80‐320 vs 89.1; IQR, 40‐160; P < 0.001). After adjusting for potential confounders, Uygur ethnicity (odds ratios [OR], 5.96; 95% CI, 4.05‐8.90), age greater than or equal to 50 years (OR, 1.84; 95% CI, 1.24‐2.77), and preference for meat diet (OR, 2.15; 95% CI, 1.05‐4.46) were significantly associated with increased odds of KSHV seropositivity.Conclusion: The study demonstrated high prevalence and correlates of KSHV infection in both Han and Uygur populations in Xinjiang, China. There is an urgent need for programmatic adaptation to address primary prevention interventions of KSHV infection in this endemic region.
- Open Access
- 25 October 2017
- Published by Elsevier in Virologica Sinica
- Vol. 32 (5) , 396-403
Prevalence of Kaposi’s sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang, China
- 25 October 2017
- Published by Elsevier in Virologica Sinica
- Vol. 32 (5) , 396-403
Open AccessPrevalence of Kaposi’s sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang, China
- 13 October 2017
- Published by Elsevier in Virologica Sinica
- Vol. 32 (5) , 415-422
Prevalence of Kaposi’s sarcoma-associated herpesvirus among intravenous drug users: a systematic review and meta-analysis
- 13 October 2017
- Published by Elsevier in Virologica Sinica
- Vol. 32 (5) , 415-422
Prevalence of Kaposi’s sarcoma-associated herpesvirus among intravenous drug users: a systematic review and meta-analysis
- Open Access
Genotypic Analysis of Kaposi’s Sarcoma-Associated Herpesvirus from Patients with Kaposi’s Sarcoma in Xinjiang, China
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the causal agent of all forms of Kaposi’s sarcoma (KS), including AIDS-KS, endemic KS, classic KS and iatrogenic KS. Based on Open reading frame (ORF) K1 sequence analysis, KSHV has been classified into seven major molecular subtypes (A, B, C, D, E, F and Z). The distribution of KSHV strains varies according to geography and ethnicity. Xinjiang is a unique region where the seroprevalence of KSHV is significantly higher than other parts of China. The genotyping of KSHV strains in this region has not been thoroughly studied. The present study aimed to evaluate the frequency of KSHV genotypes isolated from KS tissues in Classical KS and AIDS KS patients from Xinjiang, China. ORF-K1 of KSHV from tissue samples of 28 KS patients was amplified and sequenced. Two subtypes of KSHV were identified according to K1 genotyping. Twenty-three of them belonged to subtype A, while five of them were subtype C. More genotype A than genotype C strains were found in both Classical KS and AIDS KS. No significant difference was found in the prevalence of different genotype between Classical KS and AIDS KS.
Open AccessGenotypic Analysis of Kaposi’s Sarcoma-Associated Herpesvirus from Patients with Kaposi’s Sarcoma in Xinjiang, China
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the causal agent of all forms of Kaposi’s sarcoma (KS), including AIDS-KS, endemic KS, classic KS and iatrogenic KS. Based on Open reading frame (ORF) K1 sequence analysis, KSHV has been classified into seven major molecular subtypes (A, B, C, D, E, F and Z). The distribution of KSHV strains varies according to geography and ethnicity. Xinjiang is a unique region where the seroprevalence of KSHV is significantly higher than other parts of China. The genotyping of KSHV strains in this region has not been thoroughly studied. The present study aimed to evaluate the frequency of KSHV genotypes isolated from KS tissues in Classical KS and AIDS KS patients from Xinjiang, China. ORF-K1 of KSHV from tissue samples of 28 KS patients was amplified and sequenced. Two subtypes of KSHV were identified according to K1 genotyping. Twenty-three of them belonged to subtype A, while five of them were subtype C. More genotype A than genotype C strains were found in both Classical KS and AIDS KS. No significant difference was found in the prevalence of different genotype between Classical KS and AIDS KS.